Accelagen Pty Ltd

Accelagen Pty Ltd

Accelagen is a leading global contract research organisation (CRO), co-creating meaningful outcomes that have a tangible impact on the future of human health.

Visit Website

Locations

  • APAC
  • Australia
  • Europe
  • North America

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • CNS
  • Dental and Oral Health
  • Dermatology
  • Devices and Diagnostics
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • Genetic Diseases
  • Hematology
  • Hepatology
  • Immunology
  • Infectious Diseases
  • Inflammation
  • Internal Diseases
  • Metabolic Diseases
  • Musculoskeletal
  • Nephrology
  • Neurology
  • Nutrition and Health
  • Obstetrics / Gynecology
  • Oncology
  • Ophthalmology
  • Orthopedics
  • Otolaryngology/ENT (Ear/Nose/Throat)
  • Pain / Anesthesia
  • Pediatrics / Neonatology
  • Pharmacology / Toxicology
  • Podiatry
  • Psychiatry
  • Pulmonary
  • Rare Disease
  • Respiratory
  • Rheumatology
  • Sleep
  • Surgery
  • Thrombosis
  • Urology
  • Vaccines
  • Women's Health

We believe the future of human health needs a fresh, future-focused approach. Founded in 2010, Accelagen was borne out of Greg and Rosa Plunkett’s passion and career as values-driven, outcome-focussed regulatory affairs and clinical development professionals.

From the outset, Accelagen has a demonstrated track record delivering services beyond a simple transaction. We focus on your end goal and design the right strategy to get you there faster, whilst contributing the out collective mission, to create a difference to the future of human health.

We challenge existing conventions to deliver commercially savvy and patient-centric outcomes for leading biopharmaceutical and medical device companies in the fast-growing global trials market across Australia, North America, Asia Pacific, and Europe. We offer strategic direction and consultation from concept through to commercialisation.

We prioritise understanding where you are on your journey and the broader context of impact you hope to have. Our process is collaborative and patient-centred. It draws upon our extensive industry experience and supports you to deliver a comprehensive and robust product to market, faster. It’s this unique and innovative approach that creates a marked difference in the outcomes we generate for you.

Accreditations

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.